ArticleBMJ open2021

Treatment of early-stage breast cancer with percutaneous thermal ablation, an open-label randomised phase 2 screening trial: rationale and design of the THERMAC trial.

Elles M F van de Voort et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.